Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
0.4%
Debt
6.9%
Liquidity
4.9%
Revenue
Debt
Liquidity
0.4%
INR Crores
Pharmaceuticals | ₹1,657.42 |
Export Benefits | ₹37.77 |
Other Operating Revenue | ₹9.71 |
Other Income | ₹24.45 |
INR Crores
Net Gain on Sale of Investments | ₹6.47 |
INR Crores
Interest income | ₹0.67 |
INR Crores
Revenue from Questionable Sources: | ₹6.47 |
Revenue from Non Compliant Sources: | ₹0.67 |
Total: | ₹7.14 |
Total Revenue: | ₹1,736.49 |
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
₹7.14
₹1,736.49
= 0.4%
compliant
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.